All news from Thoracic Medicine

WCLC Study: Women with Non-Small Cell Lung Cancers Live Longer Than Men

Women diagnosed with non-small cell lung cancers (NSCLC) live longer than their male counterparts, according to results of a SWOG study presented by Kathy Albain, MD, the Huizenga Family Endowed Chair in Oncology Research at Loyola University Chicago Stritch School of Medicine, at the International Association for the Study of Lung Cancer's (IASLC's) 19th World Conference on Lung Cancer (WCLC) in Toronto, Ontario, Canada.

Higher Risk Of Suicide In COPD Patients With Post-Traumatic Stress Disorder

People suffering from two common conditions post-traumatic stress disorder (PTSD) and the breathing disorder known as a chronic obstructive pulmonary disease (COPD), may be increasing their risk for suicide if they take benzodiazepine drugs, a new study suggests.

Benzodiazepines include powerful drugs such as Ativan, Valium, and Xanax. These medications are prescribed to people with PTSD to ease anxiety, insomnia or shortness of breath. The study was published in the Annals of the American Thoracic Society.

Discharge After Major Heart Surgery May Impact Hospital Readmissions

Despite a common belief that weekend and holiday discharge after major heart surgery may impact hospital readmissions. The study was published online in  The Annals of Thoracic Surgery showed that the day of discharge does not affect readmissions.

Because the rate of rehospitalization after major cardiac surgery has been reported up to 22%, an investigation of potentially modifiable elements in the discharge process has led our group to determine whether the day of discharge affects readmission performance.

SimpliciTB: Testing Four-Drug Regimen Against Tuberculosis

TB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether a new four-drug regimen can treat most types of tuberculosis (TB) including multidrug-resistant TB (MDR-TB) more quickly and effectively than currently-available treatments.

The first patients have been enrolled at the National Center for Tuberculosis and Lung Disease in Tbilisi, Georgia. SimpliciTB is expected to enroll 450 people with TB, including up to 150 with MDR-TB across at least 26 centers in 10 countries in Africa, Asia, Europe and Latin America.

Severe asthma: Insights Yeilds NET results

Of the more than 24 million people in the U.S. who have asthma, 10% have severe asthma—a form of the disease that does not respond to treatment. The immunological mechanisms underlying severe asthma and asthmatic lung inflammation are not well understood.

A new study by investigators from Brigham and Women's Hospital published this week in Science Immunology models allergic lung inflammation and provides new insights into how asthma develops and progresses, with important implications for the most clinically advanced drugs designed to treat severe asthma.

Tuberculosis: Nanomedicine could Revolutionise Treatment

Tuberculosis is one of the world's deadliest infectious disease. Worldwide, there are still about 10.4 million cases of TB and 1.7 million deaths every year. One of the reasons it's been hard to bring the disease under control is that the drugs used to treat it require a gruelling regimen and can be toxic. This means people very often don't finish the course.